Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment

Journal of Nuclear Medicine

Volumn 54, Issue 8, 2013, Pages 1278-1284

  Cross, Donna J ^a   Anzai, Yoshimi ^a   Petrie, Eric C ^a,b   Martin, Nathalie ^a   Richards, Todd L ^a   Maravilla, Kenneth R ^a   Peskind, Elaine R ^a,b   Minoshima, Satoshi ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Education   (United States)

Author keywords

18F FDG PET; Alzheimer's disease; DTI; Fiber tract integrity; Glucose metabolism; Olfactory tract

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AGING; ANTERIOR CINGULATE; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; INSULA; MALE; MILD COGNITIVE IMPAIRMENT; NERVE CELL LESION; NERVE FIBER DEGENERATION; NEUROIMAGING; OLFACTORY TRACT; ORBITAL CORTEX; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SMELLING DISORDER; SUPERIOR TEMPORAL GYRUS; THALAMUS DORSOMEDIAL NUCLEUS; UNCUS;

18F-FDG PET; ALZHEIMER'S DISEASE; DTI; FIBER TRACT INTEGRITY; GLUCOSE METABOLISM; OLFACTORY TRACT;

AGED; AGING; ANISOTROPY; AXONS; CASE-CONTROL STUDIES; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NERVE NET; OLFACTORY PATHWAYS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84881452714     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.116558     Document Type: Article

References (32)

1. Albers MW, Tabert MH, Devanand DP. Olfactory dysfunction as a predictor of neurodegenerative disease. Curr Neurol Neurosci Rep. 2006;6:379-386.
2. Bahar-Fuchs A, Chételat G, Villemagne VL, et al. Olfactory deficits and amyloid-b burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study. J Alzheimers Dis. 2010;22:1081-1087.
3. Duda JE. Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci. 2010;289:49-54.
4. Ross G, Abbott R, Petrovitch H, et al. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord. 2006;21:2062-2067.
5. Scherfler C, Schocke MF, Seppi K, et al. Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain. 2006;129:538-542.
6. Christen-Zaech S, Kraftsik R, Pillevuit O, et al. Early olfactory involvement in Alzheimer's disease. Can J Neurol Sci. 2003;30:20-25.
7. Attems J, Jellinger K. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin Neuropathol. 2006;25:265-271.
8. Hyman BT, Arriagada PV, Van HGW. Pathologic changes in the olfactory system in aging and Alzheimer's disease. Ann N Y Acad Sci. 1991;640:14-19.
9. Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Neuropathol Appl Neurobiol. 2003;29:503-510.
10. Kovács T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Res Rev. 2004;3:215-232.
11. Cross DJ, Flexman JA, Anzai Y, Maravilla KR, Minoshima S. Age-related decrease in axonal transport measured by MR imaging in vivo. Neuroimage. 2008;39:915-926.
12. Minoshima S, Cross D. In vivo imaging of axonal transport using MR imaging: aging and Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2008;35(suppl 1): S89-S92.
13. Thomann PA, Dos Santos V, Seidl U, Toro P, Essig M, Schröder J. MR imagingderived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2009;17:213-221.
14. Bohnen NI, Djang DSW, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med. 2012;53:59-71.
15. Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer's disease. Lancet. 1994;344:895.
16. Reiman E, Caselli R, Yun L, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 1996;334:752-758.
17. Westin C-F, Maier SE, Mamata H, Nabavi A, Jolesz FA, Kikinis R. Processing and visualization for diffusion tensor MR imaging. Med Image Anal. 2002;6: 93-108.
18. Mac Donald CL, Dikranian K, Bayly P, Holtzman D, Brody D. Diffusion tensor imaging reliably detects experimental traumatic axonal injury and indicates approximate time of injury. J Neurosci. 2007;27:11869-11876.
19. Chen TF, Lin CC, Chen YF, et al. Diffusion tensor changes in patients with amnesic mild cognitive impairment and various dementias. Psychiatry Res. 2009; 173:15-21.
20. Zhang Y, Schuff N, Jahng G-H, et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology. 2007;68:13-19.
21. Zhou Y, Dougherty JH, Hubner KF, Bai B, Cannon RL, Hutson RK. Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment. Alzheimers Dement. 2008;4:265-270.
22. Magistretti P, Pellerin L. Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes. Cereb Cortex. 1996;6:50-61.
23. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
24. Wakana S, Jiang H, Nagae-Poetscher LM, van Zijl PCM, Mori S. Fiber tractbased atlas of human white matter anatomy. Radiology. 2004;230:77-87.
25. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. 3-Dimensional Proportional System: An Approach to Cerebral Imaging. New York, NY: Thieme Medical Publishers; 1988.
26. Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med. 1994; 35:1528-1537.
27. Minoshima S, Ficaro E, Frey K, Koeppe R, Kuhl D. Data extraction from brain PET images using three-dimensional stereotactic surface projections. In: Carson R, Daube-Witherspoon M, Herscovitch P, eds. Quantitative Functional Brain Imaging with Positron Emission Tomography. San Diego, CA: Academic Press; 1998:133-137.
28. Worsley KJ, Marrett S, Neelin P, Evans AC. A unified statistical approach for determining significant signals in location and scale space images of cerebral activation. In: Myers R, Cunningham V, Bailey D, Jones T, eds. Quantification of Brain Function Using PET. San Diego, CA: Academic Press; 1996:327-333.
29. Kandel ER, Schwartz JH, Jessell TM. Principles of Neural Science. 3rd ed. East Norwalk, CT: Appleton & Lange; 1991.
30. Mosconi L, Brys M, Glodzik-Sobanska L, De Santi S, Rusinek H, de Leon MJ. Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol. 2007;42:129-138.
31. Mac Donald CL, Dikranian K, Song SK, Bayly PV, Holtzman DM, Brody DL. Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of traumatic brain injury. Exp Neurol. 2007;205:116-131.
32. Minoshima S, Cross DJ, Foster NL, Henry TR, Kuhl DE. Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease: pathophysiological implications. Ann N Y Acad Sci. 1999; 893:350-352.